KT-US-471-0140: Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleuc

Skip to Content

JavaScript has been disabled within your browser, the content or the functionality of this web page can be limited or unavailable.

There is no panel matching the key "Alert---Site-Wide"

Back to Results

KT-US-471-0140: Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel

Objective

Clinical Trial Details

Principal Investigator(s)

Waqas Jehangir, MD

Clinical Trial Categories

Leukemia
Lymphoma

Contact

Hematology Research Coordinators at 605-322-3090
or hematologyresearch@avera.org

Location

Avera Research Institute — Sioux Falls
6001 S Sharon Ave
Sioux Falls, SD 57108
Main: 605-504-3154